Skip to main content
. 2021 Jul 28;12:697840. doi: 10.3389/fimmu.2021.697840

Figure 4.

Figure 4

IFN-α treated monocytes showed enhanced peptide presentation to CD8+ T cells. (A–C) After CD14+ isolation, monocytes were incubated with IFNα overnight, loaded with different concentrations of gp100, washed, and gp100-specific CD8+ T cells were added. After 24h, IFNγ secretion by CD8+ T cells after co-culture with monocyte loaded with (B) short peptide or (C) long peptide was measured by ELISA. (D, E) Targeted antigen delivery to CD14+ CD169+ monocytes using antibody conjugated with gp100 peptide. (D) IFNα-treated CD14+ CD169high monocytes or (E) freshly-isolated total CD14+ monocytes were loaded with different doses of αCD169-gp100 or control IgG-gp100 antibody-conjugates, washed, and gp100-specific CD8+ T cells were added. After 24h IFNγ secretion was measured by ELISA. Data are mean from four donors. Paired t-tests were used. *P < 0.05, **P < 0.01, ***P < 0.001.